Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in New York, automatically classified by Maddy, our AI policy reader.

Total bills
49
119th Congress
Top supporter
Daniel S. Goldman
71% support rate
Top opponent
Nicholas A. Langworthy
33% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in New York

Legislators moving healthcare in New York
Legislator Party Stance Support rate Votes
Daniel S. Goldman
Daniel S. Goldman House · District 10
D
Support
71% 195
Alexandria Ocasio-Cortez
Alexandria Ocasio-Cortez House · District 14
D
Support
67% 208
Adriano Espaillat
Adriano Espaillat House · District 13
D
Support
67% 207
Gregory W. Meeks
Gregory W. Meeks House · District 5
D
Support
65% 208
Nydia M. Velázquez
Nydia M. Velázquez House · District 7
D
Support
61% 204
Nicholas A. Langworthy
Nicholas A. Langworthy House · District 23
R
Oppose
33% 209
Andrew R. Garbarino
Andrew R. Garbarino House · District 2
R
Mixed −
44% 204
Nicole Malliotakis
Nicole Malliotakis House · District 11
R
Mixed −
44% 207
Nick LaLota
Nick LaLota House · District 1
R
Mixed −
44% 205
Claudia Tenney
Claudia Tenney House · District 24
R
Mixed −
44% 208
Showing 1–10 of 49 bills

All healthcare bills

in committee · United States · House Jun 24, 2026

HR 9421: Ban Abortion by Mail Act

This bill, titled the Ban Abortion by Mail Act, aims to restrict how abortion medications like mifepristone are prescribed by requiring an in-person visit between the patient and the doctor. It directly affects health care providers who are currently certified by the FDA to dispense these drugs, threatening their certification status if they prescribe them without a physical examination or to patients living in states where the provider lacks a medical license. The legislation mandates that the FDA report annually to Congress on any providers who lose this certification due to violations or unsafe prescribing practices. By enforcing these specific conditions, the bill seeks to ensure that all prescriptions for abortion drugs are administered under strict supervision and within the legal boundaries of the patient's state.
in committee · United States · Senate Jul 16, 2026

SJRES 198: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".

This joint resolution seeks to officially disapprove a specific rule issued by the Centers for Medicare & Medicaid Services regarding the implementation of prior authorization for certain Medicare services. The proposed action would prevent the rule, known as the WISeR Model, from taking effect, thereby stopping the new requirements from being enforced. If passed, the resolution would nullify the regulation and maintain the status quo for the affected healthcare services.
Sub-Topics Medicaid Medicare
in committee · United States · Senate Jul 14, 2026

SJRES 197: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program".

This joint resolution seeks to formally disapprove a specific rule issued by the Centers for Medicare & Medicaid Services regarding the Affordable Care Act and the Basic Health Program for 2027. If passed, the measure would nullify the rule, preventing it from taking legal effect. The bill directly impacts the administration of healthcare benefits and payment parameters for the upcoming year. It is sponsored by a group of Democratic senators and is intended to halt the implementation of the agency's proposed changes.
Sub-Topics Medicaid Medicare
in committee · United States · House Jun 18, 2026

HJRES 197: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program".

This joint resolution expresses Congress's disapproval of a specific federal rule issued by the Centers for Medicare & Medicaid Services regarding the Affordable Care Act and the Basic Health Program for 2027. If passed, the measure would legally nullify the rule, preventing it from taking effect. The bill directly impacts the administration of healthcare benefits and payment parameters for the upcoming year by rejecting the proposed guidelines.
Sub-Topics Medicaid Medicare
in committee · United States · House Apr 30, 2026

HR 8603: Dismemberment Abortion Ban Act of 2026

HR 8603, the Dismemberment Abortion Ban Act of 2026, prohibits physicians from performing abortions that involve dismembering an unborn child and extracting it piece by piece or crushed from the uterus. The law allows exceptions only when the procedure is necessary to save the mother's life, while explicitly permitting other abortion methods for reasons such as rape or incest. It imposes criminal penalties of up to two years in prison or fines on physicians who violate the ban and creates a civil lawsuit system where women or parents of minors can seek monetary damages and attorney fees against providers. The bill also defines an 'unborn child' as a human organism from fertilization until birth and clarifies that the woman undergoing the procedure cannot be prosecuted or held financially liable.
Sub-Topics Women's Health
in committee · United States · House May 15, 2026

HR 8857: Next GEN Act of 2026

The Next GEN Act of 2026 modifies the Drug Price Negotiation Program to include a specific category of medications called engineered cyclic peptides. This change extends the time before these drugs can be negotiated for lower prices from seven years to eleven years. The bill defines these peptides as synthetic, amino acid-based drugs that are self-administered and created using genetic library screening methods. By adjusting the timeline, the legislation directly affects pharmaceutical companies and the government agencies responsible for setting drug prices under the program.
Sub-Topics Prescription Drugs
in committee · United States · Senate Jun 9, 2026

SJRES 192: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model".

This joint resolution seeks to reject a specific federal rule issued by the Centers for Medicare & Medicaid Services regarding the WISeR Model, which was designed to reduce wasteful spending by requiring prior authorization for select Medicare services. If passed, the measure would legally nullify the rule, preventing the Centers for Medicare & Medicaid Services from enforcing the new prior authorization requirements on healthcare providers. The bill directly affects Medicare beneficiaries and medical facilities that would otherwise have to comply with these administrative changes. By invoking the Congressional Review Act, the legislation aims to stop the implementation of the policy without altering the underlying statute governing Medicare.
Sub-Topics Medicaid Medicare
in committee · United States · House Sep 1, 2026

HR 7945: Nitrous Oxide Safety Act of 2026

The Nitrous Oxide Safety Act of 2026 would classify consumer products containing nitrous oxide as banned hazardous items under federal law, except for specific exceptions. The bill prohibits the sale of nitrous oxide products for recreational use while allowing continued sales for medical and dental treatments, food production in commercial kitchens, research and development activities, and food propellant applications. This legislation directly affects manufacturers, retailers, and consumers by restricting access to nitrous oxide in consumer products after 180 days from enactment. The law defines nitrous oxide as the gas known as laughing gas or whippits and specifies which entities and activities are exempt from the ban.
in committee · United States · House Jan 3, 2025

HR 199: Implementing DOGE Act

This bill requires automatic, across-the-board spending cuts to nonsecurity federal programs for fiscal years 2026 and beyond. It targets nonsecurity discretionary spending (like education, transportation, and environmental programs) by rescinding the percentage of growth above 1% compared to the previous year's funding. The cuts apply proportionally to all nonsecurity programs after appropriations are made available for the fiscal year (by September 30). Security-related spending (such as defense) is excluded from these reductions.
in committee · United States · House Mar 26, 2025

HR 2378: Defining Male and Female Act of 2025

This bill amends the U.S. Code to define key terms like "sex," "male," and "female" based on biological characteristics present at conception, specifically referencing reproductive anatomy. It requires all federal agencies, courts, and Congress to use these biological definitions when interpreting laws, regulations, or agency actions - replacing current interpretations that consider gender identity. The bill explicitly states that "gender identity" does not constitute a valid basis for determining sex under federal law. This change would directly affect how federal agencies implement existing laws related to healthcare, education, employment, and civil rights by mandating biological sex definitions in their operations.
Showing 1 to 10 of 49 bills
1 2 3 5 Next